ONEPOINT PATIENT CARE: To Open Hospice-Dedicated Pharmacy in Delaware
Expert, local dispensing and same-day delivery to be provided by experienced hospice pharmacy Read More »
CATALYST HEALTHCARE: CHC Health Partners with Catalyst Healthcare and Pack4U to Provide Virtual Pharmacist Services Targeting Medication Adherence Improvement
CHC Health has announced a strategic partnership with Catalyst Healthcare, an award-winning technology company, and Pack4U for delivery of connected care at home, to provide virtual pharmacist services for improving medication adherence and patient health outcomes. Read More »
BRYN PHARMA: Partners with Aptar Pharma for Nasal Epinephrine Treatment
Bryn's Epinephrine Nasal Spray has Two Doses in One Portable Device Read More »
EYEVANCE PHARMACEUTICALS: Acquires TOBRADEX® ST and NATACYN®
Acquisition bolsters Eyevance's position as an emerging leader in treating anterior segment and ocular surface conditions Read More »
ALLERGAN: Allergan Expands REFRESH® Portfolio With New REFRESH® RELIEVA™ Lubricant Eye Drop Product Line
A Trifecta of Relief Formulated with HydroCell™ Technology Offers New Artificial Tear Options for Patients Suffering from Eye Dryness Read More »
PANTHERX RARE: Named first national pharmacy holding an accredited distinction in rare disease
PANTHERx is excited to announce that it is the first pharmacy nationwide that has been awarded the Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). Read More »
APRECIA: Kimberly Bone, PharmD, named Aprecia's Vice President of Medical & Clinical Affairs
Former Publix Super Markets Pharmacy Executive joins company as it expands its 3D-printed product portfolio Read More »
UCF researchers awarded $400,000 grant to create new insulin delivery tube
Researchers from the University of Central Florida recently received a $400,000 grant from the Juvenile Diabetes Research Foundation, which they will use to create a tube that resists infection and encapsulation and is inserted under the skin for the delivery of insulin via a pump. Read More »
Study shows effects of body lotions on capillary blood glucose
A recent study published in European Endocrinology examined the effects of body lotions on capillary blood glucose measurement. Read More »
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: PCMA Statement on Reducing Prescription Drug Prices
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the Senate Finance Committee hearing: “Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market: “We share the Administration’s goal of reducing drug prices.” Read More »
NFL legend Boomer Esiason gives a face and voice to thousands affected by cystic fibrosis
Boomer Esiason’s commitment to enhancing the quality of life for cystic fibrosis sufferers has become the stuff of legend. Add Teaser here Read More »
NOVARTIS CORPORATION: Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
Novartis today announced that the US Food and Drug Administration (FDA) has approved Gilenya® (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis, making it the first disease-modifying therapy indicated for these patients2. Read More »
ASRAZENECA PHARMACEUTICALS LP: AstraZeneca provides update on GALATHEA Phase III trial for Fasenra in chronic obstructive pulmonary disease
AstraZeneca and MedImmune, its global biologics research and development arm, today announced top-line results from the GALATHEA Phase III trial for Fasenra (benralizumab) in patients with moderate to very severe chronic obstructive pulmonary disease (COPD). Read More »
UNITEDHEALTH GROUP: UnitedHealth Group Statement on Trump Administration’s Drug Policy Proposal
The fundamental issues with prescription drug affordability are the high prices set by and marketing practices of pharmaceutical manufacturers, so we welcome the Administration’s focus on reducing drug costs. Read More »
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: American Diabetes Association White Paper Confirms Drugmakers Set and Raise Insulin Prices
“The American Diabetes Association’s new white paper on insulin prices confirms that drugmakers set, and continue to raise, prices. Read More »
VALEANT PHARMACEUTICALS: Bausch + Lomb Launches LUMIFY, The First And Only OTC Redness Relieving Eye Drop With Low-Dose Brimonidine
Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Valeant Pharmaceuticals International (NYSE/TSX: VRX), today announced the launch of LUMIFY™ (brimonidine tartrate ophthalmic solution 0.025%), the first and only over-the-counter (OTC) eye drop developed with low-dose brimonidine tartrate for the treatment of eye redness. Read More »
OPINION: Next Step in Dismantling Obamacare: IPAB
Taxes are lower, ISIS is on the run, and the regulatory agencies are in a ceasefire with the US economy. Read More »
Rite Aid rolls out KidCents Safe Medication Disposal Program
The Rite Aid Foundation recently announced the rollout of its KidCents Safe Medication Disposal Program, which will focus on reducing drug accessibility, medication misuse and accidental poisoning of children and adolescents. Read More »
Ascend Therapeutics, Egalet Corp. offer new opioid-free painkiller delivered via nasal spray
The makers of a new, opioid-free inhalable pain reliever have launched a campaign to market the drug to more than 9,000 women’s healthcare providers across the U.S. this fall. Read More »
Novartis's Kymriah approved by FDA to treat acute lymphoblastic leukemia
Novartis recently announced that the U.S. Food and Drug Administration (FDA) approved Kymriah suspension for intravenous infusion for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse. Read More »
Alerts Sign-up